Amphora Capital was established in 2006 as the Private Investment Fund subsidiary to Amphora Corporation. The business includes equity funds, investment and management consulting business, and incubators.
Amphora Capital focuses on investment of start-up stage and growth companies, with a particular focus on potential investment opportunities in the industrial Internet, biomedical health and high technology sectors. Have invested in biopharmaceuticals, precision medicine, aerospace, education, fine chemicals and many other fields. With AUM over 10 billion RMB, it has invested in nearly 200 outstanding enterprises, and many companies have successfully listed in China. Amphora Capital always adheres to the investment principle of value and growth, giving entrepreneurs not only financial support, but also the introduction of strategic resources, the improvement of business models and the assistance of corporate follow-up financing.
Fast Equality Innovation Win-Win
Micro marketing, micro learning and micro management
Amphora Capital adheres to the investment principle of value and growth, focusing on venture capital investment in start-up and growth companies. It focuses on technological companies in precision medical and artificial intelligence industries, and new business models applied in consumption upgrade and internet-plus areas. Amphora Capital now manages 30 RMB funds with AUM over 10 billion RMB. It has invested nearly 200 outstanding enterprises, and several companies have successfully listed in China.
With ten years of accumulation, Amphora Capital has created a professional investment team with rich experience and strong characteristics, which consists of industrial management, pre-listing tutoring, management consulting and incubation services. It is committed to becoming an excellent investment institution in China, to being the most trusted long-term partner of Chinese entrepreneurs and investors, and to helping investors gain wealth and value while helping them grow.